RecruitingNCT05609318

Imaging Intravenous Iron

Study of Tissue Iron Uptake in Iron-Deficient Patients Receiving Intravenous Iron Replacement Therapy: A Prospective Observational Study (STUDY)


Sponsor

University of Oxford

Enrollment

12 participants

Start Date

Oct 29, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to track where the iron goes in different tissues in the hours, days and weeks after an intravenous iron infusion. We will track iron in tissues using MRI relaxometry parameters R1/R2/R2\* which are well established as accurate indicators of tissue iron content.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Participant is willing and able to give informed consent for participation in the study.
  • Aged 18 years or above.
  • Anaemia (haemoglobin less than 120g/L for women and less than 130g/L for men) and/or confirmed iron deficiency (ferritin less than 100mcg/L and/or transferrin saturation less than 20%).
  • Scheduled to receive intravenous iron for correction of iron deficiency.

Exclusion Criteria6

  • Any MRI incompatible implants (e.g. cardiac, neuro, ocular implants, surgical clips, aneurysm clips, shrapnel/bullets)
  • Pregnant or lactating participant
  • Acute decompensated heart failure
  • Unstable clinical status
  • Any other medical conditions which would influence the reliability of the study results determined by the investigators.
  • Any other contraindication to MRI to be confirmed by the qualified MRI operator, e.g. tattoos containing traces of metal.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR)

Oxford, Oxfordshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05609318


Related Trials